OverT

OverT Bio

This company develops engineered cell therapies and genetic screening platforms to treat patients with solid tumour cancers.

Vivere Oncotherapies

This company develops engineered cancer immunotherapies to help the immune systems of patients with solid tumours detect and destroy malignant cells.

OPS-γδ

This company develops an engineered gamma delta T cell therapy platform to treat patients with solid tumours.

Swarm Oncology

This biotechnology company develops personalised T cell therapies for patients with advanced solid cancers to achieve long-term remission.

Captain T Cell

The company develops cell therapies for cancer patients to treat solid tumours.

PanCancerT

This biotech company develops T-cell receptor therapies for patients with solid tumours, focusing on targets like triple-negative breast cancer and melanoma.

LYEL

This company develops engineered cell therapies to treat patients with solid tumours and blood cancers.

Avenge Bio

This biotechnology firm develops cell-based immunotherapies for patients with solid tumours, specifically targeting metastatic peritoneal cancers like ovarian cancer.